Common Stock, Shares, Issued of NEKTAR THERAPEUTICS from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NEKTAR THERAPEUTICS quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEKTAR THERAPEUTICS Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 20,378,832, a 58% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

NEKTAR THERAPEUTICS Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 20,378,832 +7,441,524 +58% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 19,652,513 -173,090,487 -90% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 13,009,559 -179,336,441 -93% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 194,388,000 +2,479,000 +1.3% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 12,937,308 -178,446,692 -93% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 192,743,000 +1,972,000 +1% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 192,346,000 +2,227,000 +1.2% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 191,909,000 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 191,384,000 +2,824,000 +1.5% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 190,771,000 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 190,119,000 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q4 2022 188,560,000 +3,092,000 +1.7% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q4 2021 185,468,000 +5,377,000 +3% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 180,091,000 +3,586,000 +2% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 176,505,000 +2,975,000 +1.7% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 173,530,000 +14,006,000 +8.8% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 173,057,000 +16,104,000 +10% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 172,415,000 +16,554,000 +11% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 162,379,000 +7,648,000 +4.9% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 159,524,000 +6,312,000 +4.1% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 156,953,000 +19,157,000 +14% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 155,861,000 +19,259,000 +14% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 154,731,000 +18,580,000 +14% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 153,212,000 +17,923,000 +13% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 137,796,000 +4,579,000 +3.4% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 136,602,000 +4,417,000 +3.3% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 136,151,000 +4,700,000 +3.6% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 135,289,000 +4,073,000 +3.1% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 133,217,000 +4,969,000 +3.9% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 132,185,000 +4,899,000 +3.8% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 131,451,000 +4,515,000 +3.6% 31 Mar 2015 10-Q 01 May 2015 2015 Q1
Q4 2014 131,216,000 +14,722,000 +13% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 128,248,000 +12,258,000 +11% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 127,286,000 +11,603,000 +10% 30 Jun 2014 10-Q 01 Aug 2014 2014 Q2
Q1 2014 126,936,000 +11,475,000 +9.9% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 116,494,000 +1,235,000 +1.1% 31 Dec 2013 10-K 26 Feb 2015 2014 FY
Q3 2013 115,990,000 +917,000 +0.8% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 115,683,000 +903,000 +0.79% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 115,461,000 +870,000 +0.76% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 115,259,000 +774,000 +0.68% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q3 2012 115,073,000 +647,000 +0.56% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 114,780,000 +475,000 +0.42% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 114,591,000 +568,000 +0.5% 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 114,485,000 +19,968,000 +21% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 114,426,000 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 114,305,000 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q1 2011 114,023,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 94,517,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.